The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | Common | 00032Q104 | 5,755,792 | 2,849,402 | SH | SOLE | 2,849,402 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | Common | 02043Q107 | 212,677,757 | 1,111,111 | SH | SOLE | 1,111,111 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 388,806,000 | 27,400,000 | SH | SOLE | 27,400,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | Common | 03753U106 | 665,111,104 | 11,111,111 | SH | SOLE | 11,111,111 | 0 | 0 | ||
ARGENX SE | Sponsored ADR | 04016X101 | 469,666,324 | 1,234,567 | SH | SOLE | 1,234,567 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 34,578,000 | 1,130,000 | SH | SOLE | 1,130,000 | 0 | 0 | ||
ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 473,012,152 | 3,755,555 | SH | SOLE | 3,755,555 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | Common | 05370A108 | 22,715,500 | 2,510,000 | SH | SOLE | 2,510,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 78,169,500 | 13,050,000 | SH | SOLE | 13,050,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 414,606,000 | 4,300,000 | SH | SOLE | 4,300,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG | Common | 15678U128 | 320,355,532 | 7,555,555 | SH | SOLE | 7,555,555 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | Common | 23257D103 | 262,444,442 | 11,111,111 | SH | SOLE | 11,111,111 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 13,464,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
IMMUNOGEN INC | Common | 45253H101 | 25,943,750 | 875,000 | SH | SOLE | 875,000 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | Common | 46116X101 | 161,542,849 | 2,255,555 | SH | SOLE | 2,255,555 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 54,471,000 | 6,700,000 | SH | SOLE | 6,700,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | Common | 48576A100 | 39,563,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | Common | 501147102 | 318,282,753 | 2,565,555 | SH | SOLE | 2,565,555 | 0 | 0 | ||
KURA ONCOLOGY INC | Common | 50127T109 | 42,852,400 | 2,980,000 | SH | SOLE | 2,980,000 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | Common | 501575104 | 96,111,500 | 3,775,000 | SH | SOLE | 3,775,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 437,050,905 | 1,888,888 | SH | SOLE | 1,888,888 | 0 | 0 | ||
MANNKIND CORP | Common | 56400P706 | 32,760,000 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | Common | 56854Q200 | 34,240,500 | 3,150,000 | SH | SOLE | 3,150,000 | 0 | 0 | ||
MERUS N V | Common | N5749R100 | 24,444,420 | 888,888 | SH | SOLE | 888,888 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | Common | 60468T105 | 287,101,850 | 4,886,840 | SH | SOLE | 4,886,840 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | Common | 61225M102 | 25,622,750 | 4,535,000 | SH | SOLE | 4,535,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 155,806,200 | 2,580,000 | SH | SOLE | 2,580,000 | 0 | 0 | ||
NUVALENT INC | Common | 670703107 | 13,166,796 | 178,921 | SH | SOLE | 178,921 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | Common | 77313F106 | 37,789,173 | 1,260,900 | SH | SOLE | 1,260,900 | 0 | 0 | ||
ROIVANT SCIENCES LTD | Common | G76279101 | 52,232,549 | 4,651,162 | SH | SOLE | 4,651,162 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | Common | 803607100 | 418,934,735 | 4,344,444 | SH | SOLE | 4,344,444 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | Common | 834203309 | 31,596,250 | 785,000 | SH | SOLE | 785,000 | 0 | 0 | ||
SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 396,844,405 | 4,444,444 | SH | SOLE | 4,444,444 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | Common | 00773J202 | 39,578,250 | 1,839,138 | SH | SOLE | 1,839,138 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | Sponsored ADR | 86366E106 | 95,106,653 | 2,333,333 | SH | SOLE | 2,333,333 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | Common | 87164F105 | 91,242,217 | 4,222,222 | SH | SOLE | 4,222,222 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | Common | 877619106 | 7,709,332 | 4,355,555 | SH | SOLE | 4,355,555 | 0 | 0 | ||
TOURMALINE BIO INC | Common | 89157D105 | 22,734,895 | 868,407 | SH | SOLE | 868,407 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL INC | Common | 90400D108 | 16,737,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | Common | 91307C102 | 628,640,882 | 2,858,888 | SH | SOLE | 2,858,888 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | Common | 92511W108 | 29,279,993 | 3,999,999 | SH | SOLE | 3,999,999 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | Common | 98420N105 | 261,006,636 | 5,666,666 | SH | SOLE | 5,666,666 | 0 | 0 |